| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 935,500 | 919,200 | 913,000 | 1,078,600 | | Cost of Revenue | 549,100 | 552,600 | 551,900 | 686,500 | | | Gross Profit | 386,400 | 366,600 | 361,100 | 392,100 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 248,600 | 222,900 | 277,900 | 197,200 | | Non Recurring | 35,600 | (9,100) | 9,100 | 60,500 | | Others | (7,200) | 2,100 | 5,100 | 7,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 109,400 | 150,700 | 69,000 | 127,400 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (14,100) | (35,800) | 700 | (102,400) | | Earnings Before Interest And Taxes | 95,300 | 114,900 | 69,700 | 25,000 | | Interest Expense | 15,500 | 16,200 | 17,000 | 20,100 | | Income Before Tax | 79,800 | 98,700 | 52,700 | 4,900 | | Income Tax Expense | 17,700 | 26,700 | 13,700 | (1,000) | | Minority Interest | (300) | (1,200) | (700) |
-
| | | | Net Income From Continuing Ops | 64,000 | 70,800 | 38,300 | 5,900 | | | Non-recurring Events | | Discontinued Operations | (1,400) | (1,300) | (600) | (4,700) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 60,400 | 69,500 | 37,700 | 1,200 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $60,400 | $69,500 | $37,700 | $1,200 |
|
0.11% Nasdaq 0.00%
Income Statement
